Serum levels of adhesion molecules (sICAM-1, sVCAM-1 and sP-selectin) in children and adolescents with thyroid diseases;Ocena stȩżenia wybranych cza̧steczek adhezyinych (sICAM-1, sVCAM-1 i sP-selectin) u dzieci i młodzieży w chorobach gruczołu tarczowego

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 6, Issue 2, 2000, Pages 79-92

  Bossowski, Artur ^a   Urban, Miroslawa ^a   Gtko, Anna ^a   Sobotko, Jadwiga ^a   Bossowska, Anna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Disease; Intercellular adhesion molecule 1; Non toxic nodular goiter; Selectin P; Vascular cell adhesion molecule 1

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LIOTHYRONINE; PADGEM PROTEIN; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROXINE; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAVES DISEASE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; NODULAR GOITER; PROTEIN BLOOD LEVEL; SERUM; SOLUBILITY; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0034579456     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease
2. Analysis of the production of soluble ICAM-1 molecules by human cells
3. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with and without ophthalmopathy and in patients with toxic adenoma
4. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy
5. Soluble intercellular adhesion molecule-1 (sCAM-1) and Graves' disease
6. Intercellular adhesion molecule-1 (ICAM-1) in the sera of patients with Graves' disease: Correlation with disease activity and treatment status
7. Plasma selectin levels in patients with Graves' disease
8. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmolpathy
9. Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases
10. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: Role of Graves' immunoglobulins and human thyrotropin receptor
11. Interaction of P selectin (CD62) and its cellular ligand: Analysis of critical residues
12. Amelioration of antigen-induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules
13. Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM
14. Soluble ICAM-1 in paediatric connective tissue diseases
15. Leukocyte interaction with vascular endothelium
16. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands
17. Expression of membrane and soluble intercellular adhesion molecule-1 in Graves' disease
18. Cytokine regulation of cellular adhesion molecule expression in inflammation
19. The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18 and VLA-4 on monocytes and ICAM-1, VCAM-1 and other ligands on endothelium
20. Adhesion molecul expression in Graves' thyroid glands; potential relevance of granule membrane protein (GMP-140) and intercellular adhesion molecule-1 (ICAM-1) in the homing and antigen presentation processes
21. Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease with age
22. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis
23. Soluble intercellular adhesion molecule-1 concentrations in patients with subacute thyroiditis and in patients with Graves' disease with or without ophthalmopathy
24. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine-activated cultured endothelial cells
25. The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer correlation with binding to LFA-1
26. Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis
27. Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1
28. The cytokines, interleukin-1 beta, interleukin-6 and interferon-gamma upregulate the expression of intercellular adhesion molecule-1 (ICAM-1) in rat thyroid cell line, FRTL-5
29. Longitudinal study of soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' disease
30. The selectins: Vascular adhesion molecules
31. Induction of intercellular adhesion molecule-1 but not of lymphocyte function-associated antigen-3 in thyroid follicular cells
32. Circulating selectin, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hyperthyroidism
33. Characterization of molecular interaction between intercellular adhesion molecule-1 and leukocyte function associated antigen-1
34. Molecular comparison of soluble intercellular adhesion molecule (sICAM-1) and sICAM-3 binding to lymphocyte function-associated antigen-1